

A practical guide for providers: how to help patients locate Loreev XR, navigate pharmacy barriers, and maintain continuity of care in 2026.
You prescribed Loreev XR for good clinical reasons: simplified once-daily dosing, improved adherence, more consistent symptom control for your anxiety patients. But now those patients are calling back, frustrated because their pharmacy doesn't carry it, can't order it, or quoted an out-of-pocket price that's out of reach.
This guide provides actionable steps your practice can take to help patients find and access Loreev XR, along with contingency plans for when the medication remains unavailable.
Loreev XR is not in a manufacturing shortage — Almatica Pharma has not reported supply disruptions to the FDA. The problem is at the pharmacy stocking level:
The result: patients often visit multiple pharmacies before finding one that has it — or give up entirely. This creates treatment disruption risk, particularly concerning with a benzodiazepine where abrupt discontinuation poses serious safety implications.
Understanding the barriers helps you anticipate problems and counsel patients proactively:
Many commercial and Medicare Part D plans require prior authorization for Loreev XR. Some impose step therapy, requiring documented failure of or inability to use IR lorazepam. When PA requests are denied or delayed, prescriptions go unfilled, and pharmacies see even less reason to stock the product.
Retail cash price for Loreev XR ranges from $430 to $565 for 30 capsules. Even with insurance, patients may face significant copays for this non-formulary brand product. For context, generic IR lorazepam costs $5 to $29 for a 30-day supply.
Some pharmacists may be unfamiliar with Loreev XR, particularly if it hasn't been dispensed at their location before. This can lead to incorrect information being given to patients, including being told the drug "doesn't exist" or "has been discontinued."
Medfinder for Providers allows your practice to search for pharmacies with Loreev XR in stock in real time. Consider integrating this tool into your prescribing workflow:
Independent pharmacies are significantly more likely to accommodate special orders for Loreev XR. Consider identifying 1-2 independent pharmacies in your area that are willing to stock or order the medication, and build that into your referral pattern. Many independent pharmacies can receive the medication from their wholesaler within 1-2 business days.
Don't wait for the pharmacy to reject the claim. When prescribing Loreev XR, submit the prior authorization request simultaneously. Key documentation to include:
Make sure patients know about the Almatica copay savings card before they get to the pharmacy:
You can also direct patients to our patient savings guide for Loreev XR for additional discount card options.
If a patient cannot access Loreev XR despite best efforts, have a clear plan to transition them back to IR lorazepam safely:
When Loreev XR isn't available and IR lorazepam isn't the right fit, consider these alternatives based on clinical presentation:
For a patient-facing resource, share our article on alternatives to Loreev XR.
Helping patients access Loreev XR requires a more proactive approach than most prescribing workflows, but the tools exist to make it manageable. By using Medfinder for Providers, building pharmacy relationships, submitting preemptive prior authorizations, and having alternative protocols ready, you can minimize treatment disruptions and keep your patients on track.
For the clinical perspective on availability trends and prescribing considerations, see our Loreev XR shortage briefing for providers. For information on helping patients manage costs, see our provider's guide to saving patients money on Loreev XR.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.